Literature DB >> 21827802

Gut-associated lymphoid tissues for the development of oral vaccines.

Jun Kunisawa1, Yosuke Kurashima, Hiroshi Kiyono.   

Abstract

Oral vaccine has been considered to be a prospective vaccine against many pathogens especially invading across gastrointestinal tracts. One key element of oral vaccine is targeting efficient delivery of antigen to gut-associated lymphoid tissue (GALT), the inductive site in the intestine where antigen-specific immune responses are initiated. Various chemical and biological antigen delivery systems have been developed and some are in clinical trials. In this review, we describe the immunological features of GALT and the current status of antigen delivery system candidates for successful oral vaccine.
Copyright © 2011 Elsevier B.V. All rights reserved.

Mesh:

Substances:

Year:  2011        PMID: 21827802     DOI: 10.1016/j.addr.2011.07.003

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  38 in total

Review 1.  Roles of M cells in infection and mucosal vaccines.

Authors:  Miao Wang; Zeqian Gao; Zhongwang Zhang; Li Pan; Yongguang Zhang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 2.  Metabolic changes during B cell differentiation for the production of intestinal IgA antibody.

Authors:  Jun Kunisawa
Journal:  Cell Mol Life Sci       Date:  2016-11-12       Impact factor: 9.261

3.  The SRC family tyrosine kinase HCK and the ETS family transcription factors SPIB and EHF regulate transcytosis across a human follicle-associated epithelium model.

Authors:  Tsuneaki Asai; Sherie L Morrison
Journal:  J Biol Chem       Date:  2013-02-25       Impact factor: 5.157

Review 4.  From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.

Authors:  Natalie L Trevaskis; Lisa M Kaminskas; Christopher J H Porter
Journal:  Nat Rev Drug Discov       Date:  2015-10-16       Impact factor: 84.694

Review 5.  Convergence of nanotechnology and cancer prevention: are we there yet?

Authors:  David G Menter; Sherri L Patterson; Craig D Logsdon; Scott Kopetz; Anil K Sood; Ernest T Hawk
Journal:  Cancer Prev Res (Phila)       Date:  2014-07-24

6.  TIR-Domain-Containing Adapter-Inducing Interferon-β (TRIF) Regulates CXCR5+ T helper Cells in the Intestine.

Authors:  Saravana Kanagavelu; Claudia Flores; Shinichiro Hagiwara; Jose Ruiz; Jinhee Hyun; Ei E Cho; Frank Sun; Laura Romero; David Q Shih; Masayuki Fukata
Journal:  J Clin Cell Immunol       Date:  2016-09-30

7.  Development of immune and microbial environments is independently regulated in the mammary gland.

Authors:  K Niimi; K Usami; Y Fujita; M Abe; M Furukawa; Y Suyama; Y Sakai; M Kamioka; N Shibata; E J Park; S Sato; H Kiyono; H Yoneyama; H Kitazawa; K Watanabe; T Nochi; H Aso
Journal:  Mucosal Immunol       Date:  2017-12-20       Impact factor: 7.313

Review 8.  Immunomodulation for gastrointestinal infections.

Authors:  Roberto J Cieza; Anthony T Cao; Yingzi Cong; Alfredo G Torres
Journal:  Expert Rev Anti Infect Ther       Date:  2012-03       Impact factor: 5.091

9.  Enhancement of nasal HIV vaccination with adenoviral vector-based nanocomplexes using mucoadhesive and DC-targeting adjuvants.

Authors:  Yuhong Jiang; Man Li; Zhirong Zhang; Tao Gong; Xun Sun
Journal:  Pharm Res       Date:  2014-05-03       Impact factor: 4.200

Review 10.  Current state and challenges in developing oral vaccines.

Authors:  Julia E Vela Ramirez; Lindsey A Sharpe; Nicholas A Peppas
Journal:  Adv Drug Deliv Rev       Date:  2017-04-22       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.